Arcadia Biosciences (RKDA) Tops Q2 EPS by 78c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of $0.78. Revenue for the quarter came in at $1.31 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Wabtec signs $700M rail services deal for Guinea mining project
• Raytheon wins $34 million contract for V-22 software support